Efficacy of PDE5 Inhibitors in Treating ED: A Multi-Center Randomized Trial
Reading Time: 2 minutesIntroduction Erectile dysfunction (ED) represents a significant health concern affecting millions of American men, impacting their quality of life and psychological well-being. Phosphodiesterase type 5 (PDE5) inhibitors have emerged as a cornerstone in the pharmacological management of ED. This article delves into a comprehensive randomized controlled trial that assessed the efficacy of PDE5 inhibitors in treating ED among 800 American... Read more »
